SHAP ranked age, BMI, and vaginal delivery count as dominant contributors, followed by systolic blood pressure, HbA1c, PIR, ...

This study analyzes health care resource utilization and costs among patients with colorectal cancer (CRC) and ovarian cancer ...

Seshadri, MD, speaks on CLL's shift toward fixed-duration, MRD-guided regimens, MRD testing barriers, and open questions on ...

Guideline concordance with the National Comprehensive Cancer Network (NCCN) has become the common language shared by oncology payers and providers, but agreeing on the guidelines is often just the ...

A narrative review finds specialty pharmacies lack a patient-reported outcome measure built for their workflow, despite ...

Nearly all community oncology practices surveyed by the Community Oncology Alliance (COA) are now administering bispecific antibody therapy in-office, but reimbursement gaps and hospital coordination ...

Although cancer has long been the leading cost driver for employer-sponsored health plans, employers are weighing far more than spending when they evaluate cancer care, according to Karen van Caulil, ...

Clearing hepatitis C sharply reduces liver cancer risk without erasing it. Across 23 studies covering 29,395 patients, HCC occurred at 1.54 per 100 person-years after sustained virologic response ...

UVA implementation data showed injection-related reactions needing active management in 0.5% of subcutaneous administrations versus 37% with intravenous dosing, contributing $100.27 lower per-visit ...

Cost per day in dermatology was $68.76 for ruxolitinib versus $4.29 for tacrolimus, implying marked budget impact despite non-equivalence as clinical substitutes. Phase 3 efficacy and tolerability ...

As the US records its highest number of measles cases in more than 3 decades, parents heading into fall are also navigating a federal overhaul of childhood vaccine guidance. 1. An ...

Congress's Mental Health TALK SAFE Act could expand telepsychiatry access by establishing permanent telehealth prescribing ...